Michel Stul
Impact in
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 44
- Chronic Lymphocytic Leukemia Research 41
- Hematology 33
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 19
- Co-authors
- Raf SciotMaria Dêbiec‐RychterAnne HagemeijerIwona WłodarskaHerman Van den BergheBartosz WasągChris De Wolf‐PeetersJaap Verweij
- Journals
- Genes Chromosomes and Cancer (13 papers)British Journal of Haematology (9 papers)Leukemia (8 papers)Blood (7 papers)The Journal of Pathology (7 papers)
- Partner nations
- BelgiumItalyNetherlands
In The Last Decade
Michel Stul
94 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Gastroenterology 1.6k
- Genetics 1.0k
- Hematology 935
- Pathology and Forensic Medicine 1.3k
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Michel Stul
This map shows the geographic impact of Michel Stul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Stul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Stul more than expected).
Fields of papers citing papers by Michel Stul
This network shows the impact of papers produced by Michel Stul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Stul. The network helps show where Michel Stul may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel Stul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 53 | |
| 2 | KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Hit paper breakdown → | 2006 | 654 |
| 3 | 2005 | 396 | |
| 4 | 2004 | 22 | |
| 5 | 2000 | 1 | |
| 6 | Amplification of chromosome 11q23 involving the MLL gene is recurrently observed in myeloid leukemias. | 1998 | 1 |
| 7 | 1998 | 68 | |
| 8 | 1997 | 104 | |
| 9 | 1997 | 7 | |
| 10 | Chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization | 1996 | 1 |
| 11 | 1996 | 27 | |
| 12 | 1996 | 17 | |
| 13 | 1995 | 1 | |
| 14 | 1994 | 9 | |
| 15 | 1994 | 10 | |
| 16 | 1994 | 72 | |
| 17 | 1992 | 46 | |
| 18 | 1991 | 2 | |
| 19 | 1991 | 19 | |
| 20 | Comparison of Aortic Smooth-muscle Cells From Normotensive and Spontaneously Hypertensive Rats in Culture | 1983 | 1 |
About Michel Stul
Michel Stul is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Gastroenterology and Oncology, having authored 94 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (41 papers), Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (19 papers), Acute Lymphoblastic Leukemia research (15 papers), Viral-associated cancers and disorders (14 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). The work is most often cited by research in Gastroenterology (1.6k citations), Genetics (1.0k citations), Hematology (935 citations), Pathology and Forensic Medicine (1.3k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Michel Stul has collaborated with scholars based in Belgium, Italy and Netherlands. Frequent co-authors include Raf Sciot, Maria Dêbiec‐Rychter, Anne Hagemeijer, Iwona Włodarska, Herman Van den Berghe, Bartosz Wasąg, Chris De Wolf‐Peeters, Jaap Verweij, M. van Glabbeke and Ian Judson. Their work appears in journals such as Genes Chromosomes and Cancer, British Journal of Haematology, Leukemia, Blood and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.